Physician profile
Antara Mallampalli
NPI 1992885396
$2,008.70
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $592 · 2020: $222 · 2021: $371 · 2022: $803 · 2023: $21.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $371.27 | 2019-2022 | |
| Glaxosmithkline, LLC. | $308.26 | 2019-2022 | |
| Intuitive Surgical, INC. | $289.39 | 2022 | |
| Grifols USA, LLC | $163.78 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $149.02 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.31 | 2020-2022 | |
| United Therapeutics Corporation | $91.61 | 2020-2022 | |
| Genentech USA, INC. | $91.02 | 2019 | |
| Merck Sharp & Dohme LLC | $81.12 | 2019-2020 | |
| Insmed, INC. | $77.88 | 2019-2023 | Arikayce |
| Actelion Pharmaceuticals US, INC. | $71.46 | 2021-2022 | |
| Electromed, INC. | $45.96 | 2019-2022 | |
| Acacia Pharma INC | $41.47 | 2021-2022 | |
| Mylan Specialty L.P. | $29.45 | 2019-2022 | |
| Pulmonx Corporation | $25.16 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $15.93 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $14.24 | 2019 | |
| Apria Healthcare LLC | $12.94 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.25 | 2022 | |
| Phadia US INC. | $12.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antara Mallampalli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.